These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 9507998

  • 1. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H, Ninnis R, Miserez AR, Baumstark MW, Keller U.
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [Abstract] [Full Text] [Related]

  • 2. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
    Gaffney D, Forster L, Caslake MJ, Bedford D, Stewart JP, Stewart G, Wieringa G, Dominiczak M, Miller JP, Packard CJ.
    Atherosclerosis; 2002 May; 162(1):33-43. PubMed ID: 11947895
    [Abstract] [Full Text] [Related]

  • 3. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach.
    Pietzsch J, Wiedemann B, Julius U, Nitzsche S, Gehrisch S, Bergmann S, Leonhardt W, Jaross W, Hanefeld M.
    J Lipid Res; 1996 Oct; 37(10):2074-87. PubMed ID: 8906585
    [Abstract] [Full Text] [Related]

  • 4. Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation.
    Tremblay AJ, Lamarche B, Ruel IL, Hogue JC, Bergeron J, Gagné C, Couture P.
    J Lipid Res; 2004 May; 45(5):866-72. PubMed ID: 14967814
    [Abstract] [Full Text] [Related]

  • 5. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men.
    Millar JS, Lichtenstein AH, Cuchel M, Dolnikowski GG, Hachey DL, Cohn JS, Schaefer EJ.
    J Lipid Res; 1995 Jun; 36(6):1155-67. PubMed ID: 7665994
    [Abstract] [Full Text] [Related]

  • 6. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH, Watts GF, Umpleby M, Hennessy TR, Quiney JR, Sönksen PH.
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [Abstract] [Full Text] [Related]

  • 7. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD, Loehrer F, Johnson AG.
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [Abstract] [Full Text] [Related]

  • 8. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins.
    Gaw A, Packard CJ, Lindsay GM, Griffin BA, Caslake MJ, Lorimer AR, Shepherd J.
    J Lipid Res; 1995 Jan; 36(1):158-71. PubMed ID: 7706941
    [Abstract] [Full Text] [Related]

  • 9. Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer.
    Fisher WR, Zech LA, Kilgore LL, Stacpoole PW.
    J Lipid Res; 1991 Nov; 32(11):1823-36. PubMed ID: 1770302
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
    Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G, Bedynek A, Shepherd J, Seidel D.
    J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
    Hooper AJ, Heeks L, Robertson K, Champain D, Hua J, Song S, Parhofer KG, Barrett PH, van Bockxmeer FM, Burnett JR.
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
    [Abstract] [Full Text] [Related]

  • 12. Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
    Tremblay AJ, Lamarche B, Ruel IL, Hogue JC, Deshaies Y, Gagné C, Couture P.
    Atherosclerosis; 2006 Sep; 188(1):203-12. PubMed ID: 16337207
    [Abstract] [Full Text] [Related]

  • 13. Familial defective apolipoprotein B-100.
    Hansen PS.
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [Abstract] [Full Text] [Related]

  • 14. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Pimstone SN, Defesche JC, Clee SM, Bakker HD, Hayden MR, Kastelein JJ.
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):826-33. PubMed ID: 9157944
    [Abstract] [Full Text] [Related]

  • 15. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [Abstract] [Full Text] [Related]

  • 16. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Miserez AR, Keller U.
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1719-29. PubMed ID: 7583549
    [Abstract] [Full Text] [Related]

  • 17. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
    Fisher WR, Zech LA, Stacpoole PW.
    Arterioscler Thromb; 1994 Apr; 14(4):501-10. PubMed ID: 8148348
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations.
    Ooi EM, Russell BS, Olson E, Sun SZ, Diffenderfer MR, Lichtenstein AH, Keilson L, Barrett PH, Schaefer EJ, Sprecher DL.
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):459-66. PubMed ID: 22095987
    [Abstract] [Full Text] [Related]

  • 19. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.
    Arad Y, Ramakrishnan R, Ginsberg HN.
    J Lipid Res; 1990 Apr; 31(4):567-82. PubMed ID: 2351867
    [Abstract] [Full Text] [Related]

  • 20. The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemia.
    Soutar AK, Myant NB, Thompson GR.
    Atherosclerosis; 1982 Jun; 43(2-3):217-31. PubMed ID: 7115461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.